Chronic Obstructive Pulmonary Disease Medications

100/50 · 250/50 · 500/50mcg

This inhaler is developed to target chronic obstructive pulmonary disease and is indicated to alleviate airway inflammation.

50/250mg

formulated to alleviate symptoms of asthma and intended to target airway inflammation to support improved respiratory function.

100mcg

Developed for asthma indicated to alleviate airway inflammation.

100/6 · 160/4.5 · 200/6 · 400/6mcg

indicated to relieve airway obstruction and inflammation to alleviate breathing difficulties.

100/6 · 200/6 · 400/6mcg

utilized to alleviate airway inflammation, to support respiratory function.

100 · 200mcg

developed to target bronchial inflammation to manage airway hyperactivity in respiratory conditions.

50/20mcg

Utilized to manage bronchospasm to alleviate respiratory distress.

50/20mcg

Formulated to target airway constriction and indicated to support effective breathing in respiratory conditions.

500mg

Product intended to target chronic obstructive pulmonary disease and formulated to alleviate respiratory inflammation.

250/50 · 500/50mcg

Indicated to manage asthma and chronic obstructive pulmonary disease and to alleviate respiratory inflammation by opening airways and reducing swelling.

100mcg

Indicated to relieve wheezing and formulated to target bronchospasm in asthma and respiratory conditions.

100mcg

developed to alleviate symptoms of asthma and utilized to support respiratory function by dilating airways during exacerbations.

100 · 200mcg

Intended to mitigate airway inflammation, formulated to support respiratory function and help manage symptoms of chronic asthma or lung conditions.

500mg

indicated to manage inflammatory processes in the airways, utilizing enzyme inhibition to support reduction in exacerbations for patients with underlying respiratory conditions.

100mcg

Indicated to address bronchospasm in asthma and COPD patients and to alleviate breathing difficulties by relaxing muscles in the airways.

25/125 · 25/250mcg

Utilized to target asthma and COPD to support respiratory function.

9mcg

This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.

160/4.5mcg

Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.

400mg

Formulated to mitigate respiratory restriction and indicated to support ease of breathing.

200mg

designed to target constricted airways, promoting improved airflow and reducing breathing difficulty.

400mg

Indicated to address airway obstruction, formulated to support bronchial relaxation and to address respiratory distress.

9mcg

This inhaler is formulated to support respiratory function and indicated to alleviate airway narrowing in chronic obstructive pulmonary disease.

9mcg

Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.

15caps

Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.

400mg

formulated to support airway patency by relaxing bronchial smooth muscle cells.

100mcg

Indicated to address airway narrowing to alleviate symptoms.

2 · 4mg

Designed to target airway obstruction to support easier breathing.